Denovan-Wright EM - Search Results

1

Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling.

Laprairie RB, Mohamed KA, Zagzoog A, Kelly MEM, Stevenson LA, Pertwee R, Denovan-Wright EM, Thakur GA. Laprairie RB, et al. Front Mol Neurosci. 2019 Oct 18;12:257. doi: 10.3389/fnmol.2019.00257. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31680861 Free PMC article.

2

T-Type calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells and their loss after differentiation.

Hirooka K, Bertolesi GE, Kelly ME, Denovan-Wright EM, Sun X, Hamid J, Zamponi GW, Juhasz AE, Haynes LW, Barnes S. Hirooka K, et al. J Neurophysiol. 2002 Jul;88(1):196-205. doi: 10.1152/jn.2002.88.1.196. J Neurophysiol. 2002. PMID: 12091545 Free article.

3

Regulation of alpha1G T-type calcium channel gene (CACNA1G) expression during neuronal differentiation.

Bertolesi GE, Jollimore CA, Shi C, Elbaum L, Denovan-Wright EM, Barnes S, Kelly ME. Bertolesi GE, et al. Eur J Neurosci. 2003 May;17(9):1802-10. doi: 10.1046/j.1460-9568.2003.02618.x. Eur J Neurosci. 2003. PMID: 12752779

4

Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice.

McCaw EA, Hu H, Gomez GT, Hebb AL, Kelly ME, Denovan-Wright EM. McCaw EA, et al. Eur J Biochem. 2004 Dec;271(23-24):4909-20. doi: 10.1111/j.1432-1033.2004.04460.x. Eur J Biochem. 2004. PMID: 15606779 Free article.

5

Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression.

Hogel M, Laprairie RB, Denovan-Wright EM. Hogel M, et al. PLoS One. 2012;7(7):e41152. doi: 10.1371/journal.pone.0041152. Epub 2012 Jul 18. PLoS One. 2012. PMID: 22815947 Free PMC article.

6

The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcription.

Laprairie RB, Kelly ME, Denovan-Wright EM. Laprairie RB, et al. Br J Pharmacol. 2012 Dec;167(8):1583-95. doi: 10.1111/j.1476-5381.2012.02175.x. Br J Pharmacol. 2012. PMID: 22924606 Free PMC article. Review.

7

Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.

Laprairie RB, Kelly ME, Denovan-Wright EM. Laprairie RB, et al. Neuropharmacology. 2013 Sep;72:47-57. doi: 10.1016/j.neuropharm.2013.04.006. Epub 2013 Apr 16. Neuropharmacology. 2013. PMID: 23602984

8

Co-expression of the human cannabinoid receptor coding region splice variants (hCB₁) affects the function of hCB₁ receptor complexes.

Bagher AM, Laprairie RB, Kelly ME, Denovan-Wright EM. Bagher AM, et al. Eur J Pharmacol. 2013 Dec 5;721(1-3):341-54. doi: 10.1016/j.ejphar.2013.09.002. Epub 2013 Oct 1. Eur J Pharmacol. 2013. PMID: 24091169

9

Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis.

Toguri JT, Lehmann C, Laprairie RB, Szczesniak AM, Zhou J, Denovan-Wright EM, Kelly ME. Toguri JT, et al. Br J Pharmacol. 2014 Mar;171(6):1448-61. doi: 10.1111/bph.12545. Br J Pharmacol. 2014. PMID: 24308861 Free PMC article.

10

The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients.

Laprairie RB, Warford JR, Hutchings S, Robertson GS, Kelly ME, Denovan-Wright EM. Laprairie RB, et al. J Neuroimmunol. 2014 Feb 15;267(1-2):61-72. doi: 10.1016/j.jneuroim.2013.12.008. Epub 2013 Dec 12. J Neuroimmunol. 2014. PMID: 24360910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page